EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
EyePoint, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)
Close on Oct 19, 2026
- Market cap
- $38.08K
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2010 to 2025
Operating margin
-776.0%−667.7 pts over 5 years
Net margin
-739.4%−607.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -27.5% | -8.8% | -1.8% | +1.7% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2015 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 33.2% | – | -72.2% | |
| Return on assets | 23.1% | – | -59.3% | |
| Current ratio | 8.91 | 4.24 | 8.88 | |
| Debt to equity | – | 2.05 | – | |
| Interest coverage | – | -5.1× | -7376.8× | |
| Capex to revenue | 0.6% | 1.1% | 10.5% | |
| Diluted shares | 3M | 13M | 0M |
Where the cash went
Fiscal 2021 to 2025, five years combined
EyePoint generated $483.31M from operations and spent $13.12M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$483.31M
Used
$13.12M
Capital expenditure$13.12M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-739.4%
×Asset turnover0.08×
×Equity multiplier1.22×
=Return on equity, FY2025-72.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -739.4% | 0.08× | 1.22× | -72.2% |
| FY2024 | -302.4% | 0.11× | 1.28× | -43.4% |
| FY2023 | -153.8% | 0.17× | 1.48× | -39.0% |
| FY2022 | -247.0% | 0.19× | 1.58× | -72.8% |
| FY2021 | -158.1% | 0.21× | 1.75× | -57.6% |
| FY2018 | -1795.7% | 0.07× | 3.61× | -425.0% |
| FY2017 | -245.2% | 0.30× | 1.47× | -108.0% |
| FY2016 | -1330.1% | 0.05× | 1.45× | -97.4% |
| FY2015 | 23.9% | 0.97× | 1.44× | 33.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
1of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$231.96M
- Cash generatingOperating cash flow above zero-$240.11M
- Return on assets improvedROA up on the prior year-36.8% → -55.4%
- Earnings backed by cashOperating cash flow above net income-$240.11M vs -$231.96M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose7.81 → 8.88
- No dilutionShare count did not rise0M → 0M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.12 → 0.07